ManagementOrchid Chemicals reports Rs 13.2 cr loss
Orchid Chemicals & Pharmaceuticals reported a net loss of Rs 13.20 crore for the quarter ending on September 30, 2009 as compared to Rs 40.66 crore loss last year.
- Aurobindo gets nod to market 2 more products in S Africa - Glenmark Pharma Q2 net dips 31% to Rs 81 cr - Natco to make 10 mn strips of generic Tamiflu available by Oct - Orchid gets ANDA"s final nod from USFDA for Zaleplon Capsules - Orchid Pharma settles patent row, stock up 4% - Orchid Pharma settles patent row with Schering-Plough
Total income rose to Rs 304.84 crore from Rs 339.14 crore, a drop of 10 per cent, the company said in a filing to the Bombay Stock Exchange (BSE).
Shares of the company settled at Rs 153.5, down 3.52 per cent on the BSE today.